10-Q Filing

CVS HEALTH CORP CIK: 64803 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0000064803-20-000015`
Period End Date	20200331
Filing Date	20200506
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	a0331202010-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 100 Income Statement 40 Cash Flow Statement 76 Stockholders Equity 32 Comprehensive Income 16

Balance Sheet 100 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.08B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.68B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.37B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.63B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$19.62B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$23.04B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Inventories	`InventoryNet`	$17.52B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Inventories	`InventoryNet`	$16.98B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.23B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.73B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.11B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$58.96B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$50.30B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$17.31B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$16.84B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	424.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.04B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$12.15B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.67B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.86B	USD	Point-in-time
Goodwill	`Goodwill`	$79.99B	USD	Point-in-time
Goodwill	`Goodwill`	$79.75B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$33.12B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$32.73B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.55B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.46B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.60B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.75B	USD	Point-in-time
Total assets	`Assets`	$230.64B	USD	Point-in-time
Total assets	`Assets`	$222.45B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.22B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$10.49B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$15.45B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$13.60B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$7.58B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.88B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.99B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$3.11B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$13.57B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$12.13B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.83B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.77B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.60B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.76B	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$255.00M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	-	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.78B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$5.83B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$53.30B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$59.56B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.93B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.74B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$65.73B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$64.70B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.29B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.12B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.55B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.46B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.44B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.34B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.12B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.16B	USD	Point-in-time
Total liabilities	`Liabilities`	$158.28B	USD	Point-in-time
Total liabilities	`Liabilities`	$165.16B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,729 shares issued and 1,305 shares outstanding at March 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.97B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,729 shares issued and 1,305 shares outstanding at March 31, 2020 and 1,727 shares issued and 1,302 shares outstanding at December 31, 2019 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$46.18B	USD	Point-in-time
Treasury stock, at cost: 424 shares at March 31, 2020 and 425 shares at December 31, 2019	`TreasuryStockValue`	$28.18B	USD	Point-in-time
Treasury stock, at cost: 424 shares at March 31, 2020 and 425 shares at December 31, 2019	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$46.45B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$45.11B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$687.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$1.02B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$65.14B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$63.86B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$334.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$306.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$222.45B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$230.64B	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$17.64B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$16.28B	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$249.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$162.00M	USD	1 Quarter
Total revenues	`Revenues`	$61.65B	USD	1 Quarter
Total revenues	`Revenues`	$66.75B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$40.35B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$37.25B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$13.46B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$14.39B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.25B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.56B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$63.30B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$58.96B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$2.69B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$3.46B	USD	1 Quarter
Interest expense	`InterestExpense`	$733.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$782.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$54.00M	USD	1 Quarter
Other income	`OtherNonoperatingIncomeExpense`	$31.00M	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.94B	USD	1 Quarter
Income before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.78B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$512.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$767.00M	USD	1 Quarter
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$1.42B	USD	1 Quarter
Net income attributable to CVS Health	`NetIncomeLoss`	$2.01B	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.09	USD	1 Quarter
Net income per share attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.54	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.53	USD	1 Quarter
Net income per share attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.09	USD	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted average basic shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.31B	shares	1 Quarter
Weighted average diluted shares outstanding (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter

Cash Flow Statement 76 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$58.87B	USD	1 Quarter
Cash receipts from customers	`ProceedsFromCustomers`	$63.75B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$35.65B	USD	1 Quarter
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$36.97B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$12.95B	USD	1 Quarter
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$14.30B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.19B	USD	1 Quarter
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$7.40B	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$250.00M	USD	1 Quarter
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$206.00M	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.13B	USD	1 Quarter
Interest paid	`InterestPaidNet`	$1.12B	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$53.00M	USD	1 Quarter
Income taxes paid	`IncomeTaxesPaidNet`	$65.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.31B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.95B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.99B	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.29B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$1.53B	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireInvestments`	$2.05B	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$742.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$716.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$124.00M	USD	1 Quarter
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$613.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-5.00M	USD	1 Quarter
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-10.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-891.00M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.60B	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$2.29B	USD	1 Quarter
Net borrowings of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$255.00M	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	1 Quarter
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$3.95B	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$882.00M	USD	1 Quarter
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.01B	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$649.00M	USD	1 Quarter
Dividends paid	`PaymentsOfDividends`	$652.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$101.00M	USD	1 Quarter
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$154.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$44.00M	USD	1 Quarter
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$16.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-4.00M	USD	1 Quarter
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$5.00M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.67B	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$816.00M	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.87B	USD	1 Quarter
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$4.38B	USD	1 Quarter
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.17B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.95B	USD	Point-in-time
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.11B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.09B	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$96.00M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$114.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$153.00M	USD	1 Quarter
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-35.00M	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$2.71B	USD	1 Quarter
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.99B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-1.00B	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$-541.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$389.00M	USD	1 Quarter
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.12B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.93B	USD	1 Quarter
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$-22.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$139.00M	USD	1 Quarter
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$553.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-11.00M	USD	1 Quarter
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.37B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$3.31B	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.95B	USD	1 Quarter

Stockholders Equity 32 line items

Line Item	Tag	Value	Unit	Period
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time
Net income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.43B	USD	1 Quarter
Net income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$2.01B	USD	1 Quarter
Other comprehensive loss (Note 7)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive loss (Note 7)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$208.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-53.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$657.00M	USD	1 Quarter
Other increases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-4.00M	USD	1 Quarter
Other increases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$23.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$64.17B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$65.47B	USD	Point-in-time

Comprehensive Income 16 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$2.01B	USD	1 Quarter
Net income	`ProfitLoss`	$1.43B	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$-311.00M	USD	1 Quarter
Net unrealized investment gains (losses)	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$334.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$1.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-12.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-9.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-332.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.76B	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$1.68B	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$5.00M	USD	1 Quarter
Comprehensive income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$6.00M	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.75B	USD	1 Quarter
Comprehensive income attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$1.68B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.